| 03-30-2021 | Validation of the management framework for a nonspecific human immunoglobulin shortage |
| 02-04-2025 | Use of antivirals for the treatment and prophylaxis of influenza in children and adults in the context of COVID-19 |
| 10-31-2022 | Usage optimal des immunoglobulines en fertilité, en cardiologie et autres indications |
| 12-21-2017 | Usage optimal des antipsychotiques et la prise en charge non pharmacologique des symptômes comportementaux et psychologiques de la démence chez les personnes atteintes de troubles neurocognitifs majeurs qui résident en centre d’hébergement et de soins de longue durée
|
| 03-31-2025 | Treatment of diarrhea or colitis associated with Clostridioides difficile |
| 04-11-2023 | The management of myalgic encephalomyelitis / chronic fatigue syndrome |
| 09-05-2023 | Submission of surgical specimens to the anatomic pathology laboratory:
relevance and indications |
| 12-12-2021 | Relevance of and indications for submitting surgical specimens to the anatomic pathology laboratory: obstetrics/gynecology and urology |
| 12-12-2021 | Relevance of and indications for submitting surgical specimens to the anatomic pathology laboratory: general surgery, plastic surgery and dermatology |
| 02-17-2020 | Recommendations concerning the information required to monitor nusinersen use in real-world settings |
| 01-28-2025 | Quebec's National Medical Protocol - Pharmacological treatment for fecal elimination in a person receiving palliative care or a person with a geriatric profile
|
| 08-31-2020 | Quebec's National Medical Protocol - Administration of drugs prescribed via an individual prescription in the event of distress for a person receiving palliative care |
| 07-16-2019 | Quebec's Medical Protocol - Adjustment of first-line antihypertensive medication |
| 05-26-2020 | Prevention of cardiovascular events and safety of SGLT2 inhibitors compared to DPP-4 inhibitors in a real-world setting in patients with type 2 diabetes |
| 04-15-2025 | Prévention d’une réaction d’hypersensibilité aux agents de contraste |
| 09-26-2017 | Portraits décrivant les interventions pharmacologiques et non pharmacologiques entourant le trouble du déficit de l'attention avec ou sans hyperactivité (TDAH) chez les Québécois de 25 ans et moins |
| 04-03-2018 | Portrait of opioid use in persons covered by Québec's public prescription drug insurance plan |
| 04-19-2022 | Pénurie d’immunoglobulines – traitements alternatifs aux immunoglobulines humaines non spécifiques |
| 06-10-2020 | Palivizumad (SynagisTM) |
| 01-06-2020 | Optimal usage guide for immunoglobulins in hematology |
| 04-25-2025 | National Protocol for Treatment of Chlamydia trachomatis or Neisseria
gonorrhoeae infection in an asymptomatic person |
| 07-02-2024 | Judicious blood culture use |
| 09-23-2024 | Hormone therapy for the management of the clinical manifestations of menopause |
| 06-11-2018 | Guide d'usage optimal sur l'antibioprophylaxie |
| 03-27-2015 | Guide d'usage optimal pour le traitement pharmacologique de la maladie d'Alzheimer et de la démence mixte |
| 08-09-2016 | Effet du palivizumab en prophylaxie sur la diminution des complications associées au virus respiratoire syncytial chez les enfants |
| 08-26-2019 | Dose banding and dose rounding of antineoplastic agents |
| 02-05-2021 | Confirmed Mycoplasma genitalium infection |
| 04-08-2025 | Care Management for Youth under 18 with Attention Deficit Hyperactivity Disorder (ADHD) - Report in Support of the Care Management Tool |
| 09-25-2023 | Asthma Management in Children and Adults |
